PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

From Oncology Today with Dr Neil Love Dr. Neil Love

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer.

CME information and select publications here.

Community discussion

Join the conversation

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

You May Also Like

Deep Marine Scenes

Eye On The Sky

The Grave Talks | Haunted, Paranormal & Supernatural

Real Ghost Stories Online

Sage Sociology

La Science, CQFD

Planetary Radio: Space Exploration, Astronomy and Science

Experimental History

John Michael Godier's Event Horizon

DarshanTalks Podcast